Mirum Pharmaceuticals, Inc. (MIRM) Cash flow
Market cap
$5.8B
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 0 | 0 | 1 | 3 | 11 | 24 |
| Stock-based compensation | 6 | 13 | 23 | 27 | 35 | 48 |
| Cash from operations | -39 | -89 | -133 | -120 | -71 | 10 |
| Capital expenditures | -0 | -0 | -0 | -0 | -0 | -1 |
| Cash from investing | -128 | 38 | 49 | 8 | -107 | -90 |
| Cash from financing | 127 | 181 | 73 | 109 | 337 | 18 |
| Free cash flow | ||||||
| FCF margin (%) | - | - |